New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives.

Br J Clin Pharmacol · 2015 · PMC4415707 · PMID 25377687

Europe PMC DOI

hedged sentence

0.0960

closest p · 1.9× alpha

0.0960

boldest claim

The sentences

did not reach statistical significanceP = 0.096so close (0.05 < p ≤ 0.1)

QVA149 reduced exacerbations by 10% compared to tiotropium (annualized rate of 0.93), but this did not reach statistical significance ( P = 0.096).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.